Baird’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-10,017
Closed -$2.13M 1388
2014
Q4
$2.13M Buy
10,017
+229
+2% +$45.5K 0.02% 534
2014
Q3
$1.74M Sell
9,788
-832
-8% -$138K 0.02% 494
2014
Q2
$1.8M Sell
10,620
-22,908
-68% -$3.57M 0.03% 510
2014
Q1
$4.16M Buy
33,528
+3,030
+10% +$369K 0.06% 308
2013
Q4
$3.39M Sell
30,498
-5,957
-16% -$569K 0.06% 354
2013
Q3
$3.3M Sell
36,455
-14,785
-29% -$1.33M 0.06% 339
2013
Q2
$4.32M Buy
+51,240
New +$5.32M 0.09% 266

Other funds holding AGN

Baird's AGN Position: Q1 2015 in Review

Baird sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 10,017 shares — an estimated $2.13M sold.

Baird first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $4.32M in Q2 2013. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Baird reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Baird sold 10,017 Allergan Inc shares in Q1 2015, an estimated $2.13M.
  • Baird first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Baird's Allergan Inc position peaked at $4.32M in Q2 2013.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.